Janssen, L. (2014). Functional interactions between ADAMTS and VEGF: a specific focus on ADAMTS3 [Doctoral thesis, Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/314977 |
![]() ![]() | Kaux, J.-F., Janssen, L., Drion, P., Nusgens, B., Libertiaux, V., Pascon, F., HEYERES, A., HOFFMANN, A., Lambert, C., LE GOFF, C., Denoël, V., Defraigne, J.-O., Rickert, M., Crielaard, J.-M., & Colige, A. (May 2014). Vascular Endothelial Growth Factor-111 (VEGF-111) and tendon healing: preliminary results in a rat model of tendon injury. Muscles, Ligaments and Tendons Journal, 4 (1 (eCollection 2014 Jan)), 25-28. doi:10.32098/mltj.01.2014.05 ![]() |
Janssen, L., Dubail, J., Dupont, L., Voz, M., Peers, B., Peyre, E., Nguyen, L., Nusgens, B., & Colige, A. (November 2013). ADAMTS-3 deficiency is embryonic lethal in mouse and zebrafish [Paper presentation]. 9TH Pan Pacific Connective Tissue Societies Symposium, Hong Kong SAR China. |
![]() ![]() | Delcombel, R., Janssen, L., Vassy, R., Gammons, M., Haddad, O., Richard, B., Letourneur, D., Bates, D., Hendricks, C., Waltenberger, J., Starzec, A., Sounni, N. E., Noël, A., Deroanne, C., Lambert, C., & Colige, A. (2013). New prospects in the roles of the C-terminal domains of VEGF-A and their cooperation for ligand binding, cellular signaling and vessels formation. Angiogenesis, 16 (2), 353-71. doi:10.1007/s10456-012-9320-y ![]() |
![]() ![]() | Kaux, J.-F., Drion, P., Colige, A., Pascon, F., Libertiaux, V., HOFFMANN, A., Janssen, L., HEYERES, A., Nusgens, B., LE GOFF, C., Gothot, A., Cescotto, S., Defraigne, J.-O., Rickert, M., & Crielaard, J.-M. (September 2012). Effects of platelet-rich plasma (PRP) on the healing of Achilles tendons of rats. Wound Repair and Regeneration, 20 (5), 748-756. doi:10.1111/j.1524-475X.2012.00826.x ![]() |
![]() ![]() | Kaux, J.-F., Drion, P., Colige, A., Pascon, F., Libertiaux, V., HOFFMANN, A., Janssen, L., HEYERES, A., Nusgens, B., LE GOFF, C., Gothot, A., Cescotto, S., Defraigne, J.-O., Rickert, M., & Crielaard, J.-M. (2012). Effects of platelet-rich plasma on the healing of tendons: animal model. In Biomedica 2012 (pp. 180). ![]() |
![]() ![]() | Labied, S., Delforge, Y., Blacher, S., Munaut, C., Signolle, N., Colige, A., Janssen, L., HENRY, L., Perrier d'Hauterive, S., JOUAN, C., Kirschvink, N., Noël, A., Nisolle, M., & Foidart, J.-M. (2012). Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation. Journal of Assisted Reproduction and Genetics, 28 (11), 1009. ![]() |
![]() ![]() | Janssen, L., Kaux, J.-F., Drion, P., Delcombel, R., Lambert, C., Denoël, V., Libertiaux, V., & Colige, A. (20 May 2011). Evaluation of the use of VEGF111 for the treatment of tendon lesions [Poster presentation]. GIGA-Cancer Days, Liège, Belgium. |
Delcombel, R., Janssen, L., Mineur, P., Sounni, N. E., Vassy, R., Richard, B., Noël, A., Deroanne, C., Colige, A., & Lambert, C. (2011). VEGF111, a diffusible and resistant-to-degradation variant of VEGF-A, induces the formation of a dense and characteristic network of small functional capillaries in vivo [Poster presentation]. 4th International Meeting on Angiogenesis, Amsterdam, Netherlands. |
Delcombel, R., Janssen, L., Vassy, R., Haddad, O., Letourneur, D., Waltenberger, J., Gammons, M., Bates, D., Deroanne, C., Lambert, C., & Colige, A. (2011). Evaluation of the potential interest of a VEGF chimeric variant (VEGF111b) in inhibition of angiogenesis [Poster presentation]. 3ème Congrès de la Société Française d'Angiogenèse, Bordeaux, France. |
Delcombel, R., Janssen, L., Vassy, R., Letourneur, D., Richard, B., Waltenberger, J., Gammons, M., Bates, D., Deroanne, C., Lambert, C., & Colige, A. (2011). Evaluation of the potential interest of VEGF chimeric variant (VEGF111b) in inhibition of angiogenesis [Poster presentation]. Angiokem, Bratislava, Slovakia. |
![]() ![]() | Kaux, J.-F., Drion, P., Libertiaux, V., Pascon, F., Colige, A., Le Goff, C., Lambert, C., Janssen, L., Nusgens, B., Gothot, A., Cescotto, S., Defraigne, J.-O., Rickert, M., & Crielaard, J.-M. (25 November 2010). Tendon lesion and VEGF-111 injection [Poster presentation]. 6th Meeting of the EFOST, Brussels, Belgium. |